These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2195736)

  • 1. [Somatomedins (insulin-like growth factors), growth hormone and chronic liver disease].
    Møller S; Becker PU
    Ugeskr Laeger; 1990 Jul; 152(28):2022-5. PubMed ID: 2195736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 1 and growth hormone in chronic liver disease.
    Møller S; Becker U
    Dig Dis; 1992; 10(4):239-48. PubMed ID: 1521351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function of the growth hormone axis--insulin-like growth factors--insulin-like growth factor binding proteins in patients with chronic liver diseases].
    Marek B; Kajdaniuk D; Borgiel-Marek H; Kos-Kudła B; Ostrowska Z; Banaś I; Siemińska L; Rzytki P; Kułakowska E; Lamch Z
    Pol Merkur Lekarski; 2001 Mar; 10(57):185-90. PubMed ID: 11398524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatomedins--insulin-like growth factors].
    Briese V; Hopp H
    Zentralbl Gynakol; 1989; 111(15):1017-24. PubMed ID: 2554621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urinary growth hormone and insulin-like growth factor I in children with chronic renal insufficiency.
    Perrone L; Sinisi AA; Criscuolo T; Manzo T; Maresca G; Bellastella A; del Gado R
    Child Nephrol Urol; 1990; 10(2):72-5. PubMed ID: 2253254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny and nutritional manipulation of the hepatic prolactin-growth hormone-insulin-like growth factor axis in the ovine fetus and in neonate and juvenile sheep.
    Hyatt MA; Walker DA; Stephenson T; Symonds ME
    Proc Nutr Soc; 2004 Feb; 63(1):127-35. PubMed ID: 15070443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors and aging.
    Hammerman MR
    Endocrinol Metab Clin North Am; 1987 Dec; 16(4):995-1011. PubMed ID: 3322823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, somatomedins, and the liver.
    Russell WE
    Semin Liver Dis; 1985 Feb; 5(1):46-58. PubMed ID: 2984776
    [No Abstract]   [Full Text] [Related]  

  • 15. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
    Tönshoff B; Schaefer F; Mehls O
    Pediatr Nephrol; 1990 Nov; 4(6):654-62. PubMed ID: 2088470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor measurements in the evaluation of growth hormone secretion.
    Furlanetto RW
    Horm Res; 1990; 33 Suppl 4():25-30. PubMed ID: 2245967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) Axis: A Treatment Strategy to Reverse the Effects of Early Life Developmental Programming.
    Reynolds CM; Perry JK; Vickers MH
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28786951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic activity in the generation of somatomedins: effects of administration of a liver extract.
    Pallotti S; Paolucci D; Isidori A
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):351-6. PubMed ID: 689794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition, somatomedins, and the brain.
    Phillips LS
    Metabolism; 1986 Jan; 35(1):78-87. PubMed ID: 3510365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of IGF paralog genes in liver and muscle of a GH-transgenic zebrafish.
    Nornberg BF; Figueiredo MA; Marins LF
    Gen Comp Endocrinol; 2016 Jan; 226():36-41. PubMed ID: 26718079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.